These results may be more pronounced with concomitant usage of PERCOCET and CYP3A4 and CYP2D6 inhibitors, notably when an inhibitor is added following a steady dose of PERCOCET is accomplished [see WARNINGS]. Monoamine oxidase inhibitors (MAOIs) could potentiate results of opioid, opioid’s active metabolite, such as respiratory despair, coma, https://billyi096vrn6.wikipowell.com/user